ゲノム編集市場は2023年から2028年に72億3,000万米ドル、予測期間中のCAGRは15.88％で成長すると予測されます。このレポートは、全体的な分析、市場規模と予測、傾向、成長ドライバー、課題、および約25のベンダーをカバーするベンダー分析を提供します。
このレポートは、現在の市場シナリオ、最新の傾向と推進力、および全体的な市場環境に関する最新の分析を提供します。市場は、ゲノム編集における急速な技術進歩、個別化医療に対する需要の増加、新規遺伝子編集プラットフォームの出現によって牽引されています。
本調査では、今後数年間のゲノム編集市場成長を促進する主な理由の1つとして、CRISPRベースの診断の台頭を挙げています。また、遺伝子編集とAIやデータ解析の統合が進み、農業や家畜へのゲノム編集導入が増加していることも、市場の大きな需要につながります。
また、本レポートには、市場の成長に影響を与える今後の傾向と課題に関する情報が含まれています。これは、企業が今後のすべての成長機会を戦略化し、活用するのに役立ちます。
この調査は、業界の主要参加者からの意見を含む一次情報と二次情報を客観的に組み合わせて実施されました。このレポートには、主要ベンダーの分析に加えて、包括的な市場とベンダーの状況が含まれています。
このレポートは、利益、価格設定、競争、プロモーションなどの主要なパラメーターの分析による複数のソースからのデータの調査、合成、合計により、市場の詳細な全体像を提示します。業界の主要な影響力を持つ企業を特定することで、さまざまな市場の側面を示します。提示されたデータは包括的で信頼性が高く、一次および二次の両方にわたる広範な研究の結果です。市場調査レポートは、正確な市場の成長を予測するための定性的および定量的調査を使用した、完全な競争状況と詳細なベンダー選択方法論および分析を提供します。
目次
Table of Contents
1 Executive Summary
1.1 Market overview
2 Market Landscape
2.1 Market ecosystem
3 Market Sizing
3.1 Market definition
3.2 Market segment analysis
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
4 Historic Market Size
4.1 Global genome editing market 2018 - 2022
4.2 End-user Segment Analysis 2018 - 2022
4.3 Delivery mode Segment Analysis 2018 - 2022
4.4 Geography Segment Analysis 2018 - 2022
4.5 Country Segment Analysis 2018 - 2022
5 Five Forces Analysis
5.1 Five forces summary
5.2 Bargaining power of buyers
5.3 Bargaining power of suppliers
5.4 Threat of new entrants
5.5 Threat of substitutes
5.6 Threat of rivalry
5.7 Market condition
6 Market Segmentation by End-user
6.1 Market segments
6.2 Comparison by End-user
6.3 Pharmaceutical and biotechnology companies - Market size and forecast 2023-2028
6.4 Academic institutes and research laboratories - Market size and forecast 2023-2028
6.5 CRO - Market size and forecast 2023-2028
6.6 Market opportunity by End-user
7 Market Segmentation by Delivery Mode
7.1 Market segments
7.2 Comparison by Delivery Mode
7.3 Ex-vivo - Market size and forecast 2023-2028
7.4 In-vivo - Market size and forecast 2023-2028
7.5 Market opportunity by Delivery Mode
8 Customer Landscape
8.1 Customer landscape overview
9 Geographic Landscape
9.1 Geographic segmentation
9.2 Geographic comparison
9.3 North America - Market size and forecast 2023-2028
9.4 Europe - Market size and forecast 2023-2028
9.5 Asia - Market size and forecast 2023-2028
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
9.7 US - Market size and forecast 2023-2028
9.8 UK - Market size and forecast 2023-2028
9.9 Germany - Market size and forecast 2023-2028
9.10 Canada - Market size and forecast 2023-2028
9.11 China - Market size and forecast 2023-2028
9.12 Market opportunity By Geographical Landscape
10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
10.4 Market trends
11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
11.3 Landscape disruption
11.4 Industry risks
12 Vendor Analysis
12.1 Vendors covered
12.2 Market positioning of vendors
12.3 AstraZeneca PLC
12.4 Caribou Biosciences Inc.
12.5 Cellectis SA
12.6 Cibus
12.7 Danaher Corp.
12.8 Editas Medicine Inc.
12.9 Egenesis
12.10 GenScript Biotech Corp.
12.11 Horizon Discovery Ltd.
12.12 Intellia Therapeutics Inc.
12.13 Merck KGaA
12.14 New England Biolabs Inc.
12.15 Precision BioSciences Inc.
12.16 Sangamo Therapeutics Inc.
12.17 Takara Bio Inc.
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
13.3 Currency conversion rates for US$
13.4 Research methodology
13.5 List of abbreviations
Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by End-user
Exhibits6: Executive Summary - Chart on Market Segmentation by Delivery Mode
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits18: Historic Market Size - Data Table on global genome editing market 2018 - 2022 ($ billion)
Exhibits19: Historic Market Size - End-user Segment 2018 - 2022 ($ billion)
Exhibits20: Historic Market Size - Delivery mode Segment 2018 - 2022 ($ billion)
Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
Exhibits23: Five forces analysis - Comparison between 2023 and 2028
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits29: Chart on Market condition - Five forces 2023 and 2028
Exhibits30: Chart on End-user - Market share 2023-2028 (%)
Exhibits31: Data Table on End-user - Market share 2023-2028 (%)
Exhibits32: Chart on Comparison by End-user
Exhibits33: Data Table on Comparison by End-user
Exhibits34: Chart on Pharmaceutical and biotechnology companies - Market size and forecast 2023-2028 ($ billion)
Exhibits35: Data Table on Pharmaceutical and biotechnology companies - Market size and forecast 2023-2028 ($ billion)
Exhibits36: Chart on Pharmaceutical and biotechnology companies - Year-over-year growth 2023-2028 (%)
Exhibits37: Data Table on Pharmaceutical and biotechnology companies - Year-over-year growth 2023-2028 (%)
Exhibits38: Chart on Academic institutes and research laboratories - Market size and forecast 2023-2028 ($ billion)
Exhibits39: Data Table on Academic institutes and research laboratories - Market size and forecast 2023-2028 ($ billion)
Exhibits40: Chart on Academic institutes and research laboratories - Year-over-year growth 2023-2028 (%)
Exhibits41: Data Table on Academic institutes and research laboratories - Year-over-year growth 2023-2028 (%)
Exhibits42: Chart on CRO - Market size and forecast 2023-2028 ($ billion)
Exhibits43: Data Table on CRO - Market size and forecast 2023-2028 ($ billion)
Exhibits44: Chart on CRO - Year-over-year growth 2023-2028 (%)
Exhibits45: Data Table on CRO - Year-over-year growth 2023-2028 (%)
Exhibits46: Market opportunity by End-user ($ billion)
Exhibits47: Data Table on Market opportunity by End-user ($ billion)
Exhibits48: Chart on Delivery Mode - Market share 2023-2028 (%)
Exhibits49: Data Table on Delivery Mode - Market share 2023-2028 (%)
Exhibits50: Chart on Comparison by Delivery Mode
Exhibits51: Data Table on Comparison by Delivery Mode
Exhibits52: Chart on Ex-vivo - Market size and forecast 2023-2028 ($ billion)
Exhibits53: Data Table on Ex-vivo - Market size and forecast 2023-2028 ($ billion)
Exhibits54: Chart on Ex-vivo - Year-over-year growth 2023-2028 (%)
Exhibits55: Data Table on Ex-vivo - Year-over-year growth 2023-2028 (%)
Exhibits56: Chart on In-vivo - Market size and forecast 2023-2028 ($ billion)
Exhibits57: Data Table on In-vivo - Market size and forecast 2023-2028 ($ billion)
Exhibits58: Chart on In-vivo - Year-over-year growth 2023-2028 (%)
Exhibits59: Data Table on In-vivo - Year-over-year growth 2023-2028 (%)
Exhibits60: Market opportunity by Delivery Mode ($ billion)
Exhibits61: Data Table on Market opportunity by Delivery Mode ($ billion)
Exhibits62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits63: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits64: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits65: Chart on Geographic comparison
Exhibits66: Data Table on Geographic comparison
Exhibits67: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits68: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits69: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits70: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits71: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits72: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits73: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits74: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits75: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits76: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits77: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits78: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits83: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibits84: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibits85: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits86: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits87: Chart on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits88: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits89: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits90: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits91: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits92: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits93: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits94: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits95: Chart on Canada - Market size and forecast 2023-2028 ($ billion)
Exhibits96: Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
Exhibits97: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibits98: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibits99: Chart on China - Market size and forecast 2023-2028 ($ billion)
Exhibits100: Data Table on China - Market size and forecast 2023-2028 ($ billion)
Exhibits101: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits102: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits103: Market opportunity By Geographical Landscape ($ billion)
Exhibits104: Data Tables on Market opportunity By Geographical Landscape ($ billion)
Exhibits105: Impact of drivers and challenges in 2023 and 2028
Exhibits106: Overview on Criticality of inputs and Factors of differentiation
Exhibits107: Overview on factors of disruption
Exhibits108: Impact of key risks on business
Exhibits109: Vendors covered
Exhibits110: Matrix on vendor position and classification
Exhibits111: AstraZeneca PLC - Overview
Exhibits112: AstraZeneca PLC - Product / Service
Exhibits113: AstraZeneca PLC - Key news
Exhibits114: AstraZeneca PLC - Key offerings
Exhibits115: Caribou Biosciences Inc. - Overview
Exhibits116: Caribou Biosciences Inc. - Product / Service
Exhibits117: Caribou Biosciences Inc. - Key offerings
Exhibits118: Cellectis SA - Overview
Exhibits119: Cellectis SA - Product / Service
Exhibits120: Cellectis SA - Key offerings
Exhibits121: Cibus - Overview
Exhibits122: Cibus - Product / Service
Exhibits123: Cibus - Key offerings
Exhibits124: Danaher Corp. - Overview
Exhibits125: Danaher Corp. - Business segments
Exhibits126: Danaher Corp. - Key news
Exhibits127: Danaher Corp. - Key offerings
Exhibits128: Danaher Corp. - Segment focus
Exhibits129: Editas Medicine Inc. - Overview
Exhibits130: Editas Medicine Inc. - Product / Service
Exhibits131: Editas Medicine Inc. - Key offerings
Exhibits132: Egenesis - Overview
Exhibits133: Egenesis - Product / Service
Exhibits134: Egenesis - Key offerings
Exhibits135: GenScript Biotech Corp. - Overview
Exhibits136: GenScript Biotech Corp. - Business segments
Exhibits137: GenScript Biotech Corp. - Key offerings
Exhibits138: GenScript Biotech Corp. - Segment focus
Exhibits139: Horizon Discovery Ltd. - Overview
Exhibits140: Horizon Discovery Ltd. - Business segments
Exhibits141: Horizon Discovery Ltd. - Key offerings
Exhibits142: Horizon Discovery Ltd. - Segment focus
Exhibits143: Intellia Therapeutics Inc. - Overview
Exhibits144: Intellia Therapeutics Inc. - Product / Service
Exhibits145: Intellia Therapeutics Inc. - Key offerings
Exhibits146: Merck KGaA - Overview
Exhibits147: Merck KGaA - Business segments
Exhibits148: Merck KGaA - Key news
Exhibits149: Merck KGaA - Key offerings
Exhibits150: Merck KGaA - Segment focus
Exhibits151: New England Biolabs Inc. - Overview
Exhibits152: New England Biolabs Inc. - Product / Service
Exhibits153: New England Biolabs Inc. - Key news
Exhibits154: New England Biolabs Inc. - Key offerings
Exhibits155: Precision BioSciences Inc. - Overview
Exhibits156: Precision BioSciences Inc. - Business segments
Exhibits157: Precision BioSciences Inc. - Key offerings
Exhibits158: Precision BioSciences Inc. - Segment focus
Exhibits159: Sangamo Therapeutics Inc. - Overview
Exhibits160: Sangamo Therapeutics Inc. - Product / Service
Exhibits161: Sangamo Therapeutics Inc. - Key offerings
Exhibits162: Takara Bio Inc. - Overview
Exhibits163: Takara Bio Inc. - Business segments
Exhibits164: Takara Bio Inc. - Key offerings
Exhibits165: Takara Bio Inc. - Segment focus
Exhibits166: Inclusions checklist
Exhibits167: Exclusions checklist
Exhibits168: Currency conversion rates for US$
Exhibits169: Research methodology
Exhibits170: Validation techniques employed for market sizing
Exhibits171: Information sources
Exhibits172: List of abbreviations
